Value of Plasma Level of Endothelin-1 and Nitric Oxide in Diabetic Nephropathy

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Kidney

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/S00596-008-0065-Y
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Chronic Inhibition of Nitric Oxide Production Aggravates Diabetic Nephropathy in Otsuka Long-Evans Tokushima Fatty Rats

  2006cited by this paper
• Sex differences and the role of sex steroids in renal injury.

  2006cited by this paper
• Pathogenic role of nitric oxide alterations in diabetic nephropathy

  2005cited by this paper
• National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

  2005cited by this paper
• Interactions between endothelin and nitric oxide in the regulation of vascular tone in obesity and diabetes.

  2004cited by this paper
• Role of nitric oxide in diabetic nephropathy.

  2004cited by this paper
• Serum and urinary nitric oxide in Type 2 diabetes with or without microalbuminuria: relation to glomerular hyperfiltration.

  2003cited by this paper
• Paradoxes of nitric oxide in the diabetic kidney.

  2003cited by this paper
• L-arginine-nitric oxide kinetics in normal and type 2 diabetic subjects: a stable-labelled 15N arginine approach.

  2003cited by this paper
• Chronic diabetic nephropathy: role of inducible nitric oxide synthase

  2002cited by this paper
• Increased Activity of Endogenous Endothelin in Patients With Type II Diabetes Mellitus

  2002influential reference
• Plasma endothelin-1 levels and albumin excretion rate in normotensive, microalbuminuric type 2 diabetic patients.

  2002cited by this paper
• Endothelial Cell Dysfunction Leading to Diabetic Nephropathy: Focus on Nitric Oxide

  2001cited by this paper
• CyA and OxLDL cause endothelial dysfunction in isolated arteries through endothelin-mediated stimulation of O(2)(-) formation.

  2000cited by this paper
• Induction of endothelin-1 expression by glucose: an effect of protein kinase C activation.

  2000cited by this paper
• Endothelin-receptor blockade improves endothelial vasomotor dysfunction in heart failure.

  2000cited by this paper
• EFFECT OF NICARDIPINE VERSUS ENALAPRIL ON PLASMA ENDOTHELIN-1 IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES MELLITUS

  2000cited by this paper
• Acute Elevations of Plasma Asymmetric Dimethylarginine and Impaired Endothelial Function in Response to a High-Fat Meal in Patients With Type 2 Diabetes

  2000cited by this paper
• Body fat distribution predicts the degree of endothelial dysfunction in uncomplicated obesity

  1999cited by this paper
• Plasma endothelin-1 and total insulin exposure in diabetes mellitus.

  1999cited by this paper
• Enhanced, unaltered and impaired nitric oxide-mediated endothelium-dependent relaxation in experimental diabetes mellitus: importance of disease duration

  1999cited by this paper
• Unselective inhibition of endothelin receptors reduces renal dysfunction in experimental diabetes.

  1998cited by this paper
• Nitric oxide/endothelin balance after nephron reduction.

  1998cited by this paper
• Diabetic nephropathy

  1997cited by this paper
• Increased Plasma Levels of Immunoreactive Endothelin and von Willebrand Factor In NIDDM Patients

  1995cited by this paper
• Insulin modulates circulating endothelin-1 levels in humans.

  1993cited by this paper
• The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo.

  1992cited by this paper
• Elevated plasma endothelin in patients with diabetes mellitus

  1990cited by this paper

• Changing correlations among ADMA, NO and hs-CRP in normoalbuminuric and microalbuminuric patients with type 2 diabetes

  2016cites this paper